Gilead leads HIV grant­mak­ers list, tops Gates Foun­da­tion in a first for an­nu­al sur­vey

Gilead Sci­ences’ $100 mil­lion pledge to fight the HIV epi­dem­ic in the south­ern US states helped boost the bio­phar­ma to the top of an an­nu­al phil­an­thropic giv­ing list. The 19th an­nu­al study by Fun­ders Con­cerned About AIDS (FCAA) put Gilead at the top ahead of the Bill & Melin­da Gates Foun­da­tion for the first time since the study be­gan.

To­tal char­i­ta­ble giv­ing for 2020 was $707 mil­lion which, while just a 1% in­crease over the year be­fore, is still the high­est amount to date, said Sarah Hamil­ton, FCAA di­rec­tor of op­er­a­tions. FCAA tracks cash grants to ex­ter­nal or­ga­ni­za­tions for HIV re­search, treat­ment and oth­er pro­grams and does not in­clude big gov­ern­ment or pub­lic health fund­ing or in-kind con­tri­bu­tions from phar­ma com­pa­nies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER